Prof. Thumbi Mwangi
Co-Founder, Team Lead (Epi and Economics)
Quick Facts
Other Titles & Affiliations
- Associate Professor, Washington State University Paul G Allen School for Global Health
- Chancellor’s Fellow, University of Edinburgh
- Affiliate Fellow, African Academy of Sciences
- Affiliate Fellow South African Centre for Epidemiological Modelling and Analysis
Current Research
- Implementation research for the elimination of dog-mediated human rabies
- Optimal use and placement of primary healthcare services
- Improvement of essential health services
- Syndromic surveillance for early detection of zoonotic spillover
- Transmission and control of animal and human brucellosis
- Livestock interventions for improvement of human nutritional status
- Transmission dynamics and control of SARS-CoV2 in Kenya
- Analytics and epidemiological modelling to support elimination of preventative chemotherapy Neglected Tropical Diseases (NTD) in Africa, working in collaboration with the NTD modelling consortium
Thumbi Mwangi is an infectious disease epidemiologist combining classical epidemiology, applied epidemiological modelling and data science to improve the speed and quality of policy decision making in human and animal health. His research program conducts population-based studies, statistical and mathematical tools to understand the epidemiology, optimize surveillance and control of zoonotic diseases.
Research Interests
Epidemiology
Specializations
Publications
Showing 1-5 of 108 publications
On-site detection of MERS-CoV infections in a camel slaughterhouse in Kenya using a commercial rapid antigen test
Frontiers in Veterinary Science • 2025-09-15T00:00:00.000Z
Diagnostic Underuse and Antimicrobial Resistance Patterns Among Hospitalized Children in a National Referral Hospital in Kenya: A Five-Year Retrospective Study
MDPI • 2025-08-20T00:00:00.000Z
One health surveillance: linking human and animal rabies surveillance data in Kenya
Frontier Public Health • 2025-07-16T00:00:00.000Z
How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis
Ellis JR, Mutono N, Vasconcelos A, Thumbi SM, Hollingsworth TD, Anderson RM (2025) How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis. PLoS Negl Trop Dis 19(6): e0012624. https://doi.org/10.1371/journal.pntd.0012624
PLOS Neglected Tropical Diseases • 2025-06-02T02:00:00.000Z
Mortality and Predictors of Mortality Among COVID-19 Patients in Kiambu County, Kenya
MDPI • 2025-05-23T02:00:00.000Z
